Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Antigenics Inc. (ANTI)
OTHER OTC:ANTI
Antigenics (ANTI) Stock Price & Analysis
9 Followers
ANTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.01
Previous Close$0.01
Volume3.00K
Average Volume (3M)10.75K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Beta-12.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume10,750
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ANTI FAQ
What was Antigenics Inc.’s price range in the past 12 months?
Antigenics Inc. lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Antigenics Inc.’s market cap?
Currently, no data Available
When is Antigenics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Antigenics Inc.’s earnings last quarter?
Currently, no data Available
Is Antigenics Inc. overvalued?
According to Wall Street analysts Antigenics Inc.’s price is currently Overvalued.
Does Antigenics Inc. pay dividends?
Antigenics Inc. does not currently pay dividends.
What is Antigenics Inc.’s EPS estimate?
Antigenics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Antigenics Inc. have?
Antigenics Inc. has 45,844,000 shares outstanding.
What happened to Antigenics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Antigenics Inc.?
Currently, no hedge funds are holding shares in ANTI
---
Company Description
Antigenics Inc.
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.
---
Technical Analysis
---